Comment on meta-analyses of trials comparing contrast media

Radiology

Volumn 252, Issue 1, 2009, Pages 316-

  Capasso, Patrizio ^a   Weisbord, Steven D ^b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; IODIXANOL; NONIONIC CONTRAST MEDIUM;

CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; HIGH RISK PATIENT; HUMAN; KIDNEY DISEASE; LETTER; NEPHROTOXICITY; PRIORITY JOURNAL;

AGED; CONFIDENCE INTERVALS; CONTRAST MEDIA; CREATININE; FEMALE; HEART CATHETERIZATION; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; IOHEXOL; IOPAMIDOL; KIDNEY FAILURE, ACUTE; TRIIODOBENZOIC ACIDS;

EID: 67650075311     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2521090443     Document Type: Letter

References (3)

1. Heinrich MC, Häberle L, Müller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009;250(1):68-86.
2. Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008;148(4):284-294. [Published correction appears in Ann Intern Med 2008;149(3):219.]
3. Vaitkus PT, Brar C. N-acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses. Am Heart J 2007;153(2):275-280.